Skip to main navigation

Top Navigation

About Us
- Our Company
- Contact Us
Our Pipeline
- Pipeline
  - ZN-c5
  - ZN-c3
  - ZN-d5
  - ZN-e4
- Clinical Trials
Our Approach
- Integrated Discovery Engine
- Supporting Publications
Investors & Media
Careers

Investors/Media

Press Releases

Press Releases

Year

Sep 13, 2021

Zentalis Pharmaceuticals Announces First Patient Dosed in the Phase 1/2 Study of ZN-c3 in Combination with Gemcitabine in Patients with Osteosarcoma

Sep 09, 2021

Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2021

Sep 02, 2021

Zentalis Pharmaceuticals to Participate in Two Upcoming Investor Conferences

Sep 01, 2021

Zentalis Pharmaceuticals Announces Publication in the Journal of Medicinal Chemistry Highlighting the Discovery of its WEE1 Inhibitor Candidate ZN-c3

Aug 12, 2021

Zentalis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Update

Aug 04, 2021

Zentalis Pharmaceuticals to Participate in the Wedbush PacGrow Healthcare Virtual Conference

Aug 02, 2021

Zentalis Pharmaceuticals Announces First Patient Dosed in Potentially Registrational Phase 2 Study of ZN-c3 in Patients with Uterine Serous Carcinoma

Aug 02, 2021

Zentera Therapeutics Announces Closing of $75 Million Series B Financing

Jul 01, 2021

Zentalis Pharmaceuticals Announces Closing of Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Jun 28, 2021

Zentalis Pharmaceuticals Announces Pricing of Offering of Common Stock

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 23

Investors/Media

Investor Home
News & Events
- Press Releases
- Events & Presentations
Stock Information
Financials & Filings
- SEC Filings
Corporate Governance
Investor Resources

Investor Contact

Jain, Gitanjali
Solebury Trout
gogawa@soleburytrout.com

Media Contact

Julia Deutsch
Solebury Trout
jdeutsch@soleburytrout.com

“The sun is but a morning star.”

Corporate Office

530 Seventh Avenue
Suite 2201
New York, NY 10018

Science Center

10835 Road to the Cure
Suite 205
San Diego, CA 92121

For More Information

1-212-433-3791
info@zentalis.com

Footer

Privacy Policy
Terms of Use
Site Map

Copyright © 2021 Zentalis Pharmaceuticals. All Rights Reserved.